Resolution of fatty liver and weight loss: Independent associations with changes in serum lipids and apolipoproteins

被引:10
作者
Sung, Ki-Chul [1 ]
Lee, Mi-Yeon [2 ]
Lee, Jong-Young [1 ]
Lee, Sung-Ho [1 ]
Kim, Jang-Young [3 ]
Wild, Sarah H. [4 ]
Byrne, Christopher D. [5 ,6 ]
机构
[1] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Div Cardiol,Dept Internal Med, 29 Saemunan Ro, Seoul 03181, South Korea
[2] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Div Biostat,Dept R&D Management, Seoul, South Korea
[3] Yonsei Univ, Wonju Coll Med, Dept Cardiol, Wonju, South Korea
[4] Univ Edinburgh, Ctr Populat Hlth Sci, Lothian Pl, Edinburgh, Midlothian, Scotland
[5] Univ Southampton, Southampton Gen Hosp, Endocrinol & Metab Unit, IDS Bldg, Southampton, Hants, England
[6] Univ Southampton, Southampton Gen Hosp, Biomed Res Ctr, Southampton Natl Inst Hlth Res, Southampton, Hants, England
基金
英国医学研究理事会;
关键词
BMI; Obesity; Non-alcoholic fatty liver disease; Fatty liver; Lipid; Insulin resistance; Metabolic syndrome; INSULIN-RESISTANCE; HEPATIC STEATOSIS; TRIGLYCERIDE CONTENT; RISK; DISEASE; POPULATION; EXERCISE; RELIABILITY; IMPROVEMENT; PREVALENCE;
D O I
10.1016/j.atherosclerosis.2018.03.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: It is uncertain whether resolution of fatty liver can improve cardiovascular disease risk factors, independently of changes in body mass index (BMI). Our aim was to test whether resolution of fatty liver is associated with improvements in components of the lipid profile, independently of changes in BMI, and to quantify and compare the magnitude of benefit of resolution of liver fat, and decreases in BMI on the lipid profile.& para;& para;Methods: 36,195 subjects with fatty liver were studied. Persistence/resolution of fatty liver was determined by ultrasound at follow up (mean 4.93 years). Total cholesterol, triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and apolipoproteins were measured at baseline and follow up. Regression modelling was undertaken to test the independence of associations between change in fatty liver status or change in BMI, with any change in lipid profile concentrations between baseline and follow up.& para;& para;Results: Mean (SD) age was 36.3 +/- 6.6 and 39.8 +/- 8.7 years (men and women, respectively). Resolution of fatty liver occurred in 7,086, and persisted in 29,109 subjects. Mean +/- SD weight change was -3.2 +/- 4.3 (similar to 1 kg/m(2) decrease in BMI) with resolution of, and +0.5 +/- 3.5 kg with persistence of fatty liver, respectively. Both resolution of fatty liver and decrease in BMI were independently associated with improvements in all components of the lipid profile and there was a similar magnitude of benefit associated with resolution of fatty liver, or 1 kg/m(2) decrease in BMI.& para;& para;Conclusions: Resolution of fatty liver improves the lipid profile, independently of weight loss. (C) 2018 Elsevier B.V. All rights reserved.
引用
收藏
页码:47 / 53
页数:7
相关论文
共 31 条
  • [1] BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants
    Aune, Dagfinn
    Sen, Abhijit
    Prasad, Manya
    Norat, Teresa
    Janszky, Imre
    Tonstad, Serena
    Romundstad, Pal
    Vatten, Lars J.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2016, 353
  • [2] Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?
    Bhatia, Lokpal S.
    Curzen, Nicholas P.
    Calder, Philip C.
    Byrne, Christopher D.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 (10) : 1190 - +
  • [3] The burden of liver disease in Europe: A review of available epidemiological data
    Blachier, Martin
    Leleu, Henri
    Peck-Radosavljevic, Markus
    Valla, Dominique-Charles
    Roudot-Thoraval, Francoise
    [J]. JOURNAL OF HEPATOLOGY, 2013, 58 (03) : 593 - 608
  • [4] Bril F, 2017, HEPATOLOGY, V65, P1132, DOI [10.1002/hep.28985, 10.1002/hep.2]
  • [5] Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD
    Bril, Fernando
    Sninsky, John J.
    Baca, Arthur M.
    Superko, H. Robert
    Sanchez, Paola Portillo
    Biernacki, Diane
    Maximos, Maryann
    Lomonaco, Romina
    Orsak, Beverly
    Suman, Amitabh
    Weber, Michelle H.
    McPhaul, Michael J.
    Cusi, Kenneth
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (02) : 644 - 652
  • [6] Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
    Browning, JD
    Szczepaniak, LS
    Dobbins, R
    Nuremberg, P
    Horton, JD
    Cohen, JC
    Grundy, SM
    Hobbs, HH
    [J]. HEPATOLOGY, 2004, 40 (06) : 1387 - 1395
  • [7] NAFLD: A multisystem disease
    Byrne, Christopher D.
    Targher, Giovanni
    [J]. JOURNAL OF HEPATOLOGY, 2015, 62 : S47 - S64
  • [8] Ectopic fat, insulin resistance and non-alcoholic fatty liver disease
    Byrne, Christopher D.
    [J]. PROCEEDINGS OF THE NUTRITION SOCIETY, 2013, 72 (04) : 412 - 419
  • [9] Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
    Di Angelantonio, Emanuele
    Bhupathiraju, Shilpa N.
    Wormser, David
    Gao, Pei
    Kaptoge, Stephen
    de Gonzalez, Amy Berrington
    Cairns, Benjamin J.
    Huxley, Rachel
    Jackson, Chandra L.
    Joshy, Grace
    Lewington, Sarah
    Manson, JoAnn E.
    Murphy, Neil
    Patel, Alpa V.
    Samet, Jonathan M.
    Woodward, Mark
    Zheng, Wei
    Zhou, Maigen
    Bansal, Narinder
    Barricarte, Aurelio
    Carter, Brian
    Cerhan, James R.
    Collins, Rory
    Smith, George Davey
    Fang, Xianghua
    Franco, Oscar H.
    Green, Jane
    Halsey, Jim
    Hildebrand, Janet S.
    Jung, Keum Ji
    Korda, Rosemary J.
    McLerran, Dale F.
    Moore, Steven C.
    O'Keeff, Linda M.
    Paige, Ellie
    Ramond, Anna
    Reeves, Gillian K.
    Rolland, Betsy
    Sacerdote, Carlotta
    Sattar, Naveed
    Sofianopoulou, Eleni
    Stevens, June
    Thun, Michael
    Ueshima, Hirotsugu
    Yang, Ling
    Yun, Young Duk
    Willeit, Peter
    Banks, Emily
    Beral, Valerie
    Chen, Zhengming
    [J]. LANCET, 2016, 388 (10046) : 776 - 786
  • [10] Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
    Francque, Sven M.
    van der Graaff, Denise
    Kwanten, Wilhelmus J.
    [J]. JOURNAL OF HEPATOLOGY, 2016, 65 (02) : 425 - 443